Ai Ni
About
Ai Ni is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research.
According to data from OpenAlex, Ai Ni has authored 140 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 47 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Ai Ni's work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (14 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Ai Ni is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (14 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Ai Ni collaborates with scholars based in United States, Canada and France. Ai Ni's co-authors include Charles M. Rudin, Matthew D. Hellmann, Gregory J. Riely, Kwan L. Chan, Jean G. Dumesnil, Koon Teo, James W. Tam, Mark G. Kris, Jamie E. Chaft and Marc Ladanyi and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Ai Ni
126 papers receiving 6.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ai Ni United States | 36 | 3.2k | 2.1k | 1.3k | 828 | 744 | 140 | 6.2k | ||
| Leonidas G. Koniaris United States | 43 | 1.5k 0.5× | 1.7k 0.8× | 1.4k 1.1× | 840 1.0× | 1.5k 2.0× | 120 | 5.9k | ||
| Ruth A. Kleinerman United States | 45 | 1.5k 0.5× | 1.6k 0.8× | 882 0.7× | 951 1.1× | 871 1.2× | 128 | 7.5k | ||
| Michael Hauptmann Netherlands | 50 | 2.7k 0.8× | 1.9k 0.9× | 2.0k 1.6× | 348 0.4× | 1.0k 1.4× | 191 | 9.1k | ||
| Jianguang Ji Sweden | 40 | 1.1k 0.3× | 836 0.4× | 889 0.7× | 921 1.1× | 708 1.0× | 197 | 4.9k | ||
| Yawei Zhang United States | 45 | 1.2k 0.4× | 2.2k 1.0× | 1.3k 1.0× | 384 0.5× | 1.7k 2.3× | 276 | 7.4k | ||
| William H. Wallace United Kingdom | 68 | 3.0k 0.9× | 1.2k 0.6× | 3.7k 2.9× | 357 0.4× | 1.4k 1.8× | 238 | 19.1k | ||
| Preetha Rajaraman United States | 38 | 1.0k 0.3× | 1.5k 0.7× | 1.3k 1.0× | 769 0.9× | 1.1k 1.5× | 105 | 8.2k | ||
| Richard McNally United Kingdom | 42 | 2.0k 0.6× | 940 0.4× | 1.0k 0.8× | 789 1.0× | 872 1.2× | 195 | 6.4k | ||
| Peter D. Inskip United States | 52 | 1.5k 0.5× | 1.6k 0.8× | 1.2k 1.0× | 1.3k 1.5× | 918 1.2× | 138 | 8.7k | ||
| Liying Zhang Canada | 48 | 2.4k 0.8× | 5.2k 2.5× | 827 0.6× | 1.1k 1.3× | 2.4k 3.3× | 369 | 10.0k |
Countries citing papers authored by Ai Ni
Since
Specialization
Citations
This map shows the geographic impact of Ai Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ai Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ai Ni more than expected).
Fields of papers citing papers by Ai Ni
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ai Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ai Ni. The network helps show where Ai Ni may publish in the future.
Co-authorship network of co-authors of Ai Ni
This figure shows the co-authorship network connecting the top 25 collaborators of Ai Ni. A scholar is included among the top collaborators of Ai Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ai Ni. Ai Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Armstrong, Megan, Anna Price, Rebecca Coffey, et al.. (2025). Smartphone virtual reality for pain management during pediatric burn care transition: study protocol for a randomized controlled trial. Trials. 26(1). 157–157.
2.
Nusstein, John, et al.. (2024). Efficacy of Maxillary Buccal Infiltration of Articaine for Palatal Anesthesia: A Prospective, Randomized, Crossover Study. Anesthesia Progress. 71(1). 8–14.
3.
Armstrong, Megan, Rajan K. Thakkar, Renata Fabia, et al.. (2024). Features of virtual reality impact effectiveness of VR pain alleviation therapeutics in pediatric burn patients: A randomized clinical trial. SHILAP Revista de lepidopterología. 3(1). e0000440–e0000440.
4.
Armstrong, Megan, Rajan K. Thakkar, Renata Fabia, et al.. (2024). Age and Sex Differences of Virtual Reality Pain Alleviation Therapeutic During Pediatric Burn Care: A Randomized Clinical Trial. PubMed. 1(1). 163–173.
5.
Ni, Ai, Lucia A. Leone, Michael Pignone, et al.. (2024). Cluster Randomized Trial of a Church-Based Peer Counselor and Tailored Newsletter Intervention to Promote Colorectal Cancer Screening and Physical Activity Among Older African Americans. UNC Libraries.
6.
Sukumar, Jasmine, Sagar Sardesai, Ai Ni, et al.. (2024). Real‐world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer. Cancer Medicine. 13(12). e7317–e7317.
7.
Armstrong, Megan, Jonathan I. Groner, Rajan K. Thakkar, et al.. (2022). Mobile phone virtual reality game for pediatric home burn dressing pain management: a randomized feasibility clinical trial. Pilot and Feasibility Studies. 8(1). 186–186.
8.
Ni, Ai, Jacob D. Soumerai, Anna Alperovich, et al.. (2022). The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma. Leukemia & lymphoma. 63(3). 573–582.
9.
Fujiyama, Koji, Chihiro Tanikawa, Takashi Yamashiro, et al.. (2021). Comparison of clinical outcomes between Invisalign and conventional fixed appliance therapies in adult patients with severe deep overbite treated with nonextraction. American Journal of Orthodontics and Dentofacial Orthopedics. 161(4). 542–547.
10.
Watanabe, Keiichiro, Xiaohan Guo, Ai Ni, et al.. (2020). Regional variations of jaw bone characteristics in an ovariectomized rat model. Journal of the mechanical behavior of biomedical materials. 110. 103952–103952.
11.
Paik, Paul K., Rachel K. Kim, Linda S. Ahn, et al.. (2020). A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers. Clinical Cancer Research. 26(8). 1796–1802.
12.
Kumar, Anita, Fushen Sha, Ahmed Toure, et al.. (2019). Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse. Blood Cancer Journal. 9(6). 50–50.
13.
Offin, Michael, Hira Rizvi, Megan Tenet, et al.. (2018). Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR -Mutant Lung Cancers. Clinical Cancer Research. 25(3). 1063–1069.
14.
Yu, Helena A., Ken Suzawa, Emmet Jordan, et al.. (2018). Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance. Clinical Cancer Research. 24(13). 3108–3118.
15.
Santini, Fernando C., Hira Rizvi, Andrew J. Plodkowski, et al.. (2018). Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC. Cancer Immunology Research. 6(9). 1093–1099.
16.
Arbour, Kathryn C., Hyunjae R. Kim, Jordan Dienstag, et al.. (2017). Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS -Mutant Non–Small Cell Lung Cancer. Clinical Cancer Research. 24(2). 334–340.
17.
Ni, Ai, Jacob D. Soumerai, Anna Alperovich, et al.. (2017). Natural History of Hypogammaglobulinemia in Patients with Follicular Lymphoma and the Impact of Anti-CD20-Based Therapy. Blood. 130. 4054–4054.
18.
Lok, Benjamin H., Eric E. Gardner, Valentina E. Schneeberger, et al.. (2016). PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer. Clinical Cancer Research. 23(2). 523–535.
19.
Cavallo, David N., Cheryl L. Robbins, Stephanie Jilcott Pitts, et al.. (2016). Assessing the Feasibility of a Web-Based Weight Loss Intervention for Low-Income Women of Reproductive Age: A Pilot Study. JMIR Research Protocols. 5(1). e30–e30.
20.
Chan, Kwan L., Koon Teo, Jean G. Dumesnil, Ai Ni, & James W. Tam. (2010). Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis. Circulation. 121(2). 306–314.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Leonidas G. Koniaris Breakdown of academic impact, for papers by Ruth A. Kleinerman Breakdown of academic impact, for papers by Michael Hauptmann Breakdown of academic impact, for papers by Jianguang Ji Breakdown of academic impact, for papers by Yawei Zhang Breakdown of academic impact, for papers by William H. Wallace Breakdown of academic impact, for papers by Preetha Rajaraman Breakdown of academic impact, for papers by Richard McNally Breakdown of academic impact, for papers by Peter D. Inskip Breakdown of academic impact, for papers by Liying Zhang